AstraZeneca And Daiichi Sankyo's Enhertu Approved In EU For Advanced Breast Cancer Treatment

(RTTNews) - AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) Enhertu (trastuzumab deruxtecan) has been approved in the European Union as a treatment for adults with advanced breast cancer. It is for patients with unresectable or metastatic hormone receptor (HR)-posit https://www.nasdaq.com/articles/astrazeneca-and-daiichi-sankyos-enhertu-approved-eu-advanced-breast-cancer-treatment